Product Information
ARIPIPRAZOLE 5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1059 per EA under NDC 16729027910. Its NADAC has been published 480 times since Mar 15, 2017.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729027910
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA206251On Market Since
2/15/2017
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 5 MG TABLET has been published 480 times since Mar 15, 2017, and over the history we have for it it has declined 94.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1059 per EA |
|---|---|
| All-time high | $1.9371 (Mar 15, 2017) |
| All-time low | $0.0885 (Nov 20, 2024) |
| 52-week high | $0.1141 |
| 52-week low | $0.0977 |
| Median price | $0.1665 |
| Average price | $0.2651 |
| Largest weekly change | -27.5% (Apr 17, 2024) |
| Weeks tracked | 480 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1059 per EA (NDC 16729027910), effective May 20, 2026.
How has the price of ARIPIPRAZOLE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 5 MG TABLET has declined 94.5%. It has been tracked across 480 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 5 MG TABLET?
Since Mar 15, 2017, the NADAC for ARIPIPRAZOLE 5 MG TABLET has ranged from a low of $0.0885 (Nov 20, 2024) to a high of $1.9371 (Mar 15, 2017), with a median of $0.1665 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ARIPIPRAZOLE 5 MG TABLET, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 5 MG TABLET?
ARIPIPRAZOLE 5 MG TABLET (NDC 16729027910) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification